Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFIF.L Regulatory News (FIF)

  • There is currently no data for FIF

Director/PDMR Shareholding

22 Oct 2009 07:00

FINSBURY FOOD GROUP PLC

FURTHER ISSUE OF EQUITY CAPITAL AND GRANT OF SHARE OPTIONS

The Company announces that on 21st October 2009 it allotted to John Duffy, the recently appointed Group Chief Executive Officer as part of his remuneration package:

1. 201,039 new ordinary shares of 1p for no consideration: and

2. 1,038,961 new ordinary shares of 1p on payment of 19.25 pence per share.

The new ordinary shares will rank pari passu in all respects with the existing ordinary shares. Application has been made for the new ordinary shares to be admitted to trading on AIM and admission is expected to become effective on 27th October 2009.

The Board also on 21st October, 2009 granted to John Duffy options to subscribe for a total of 1,260,000 new ordinary shares of 1p each in the capital of the Company within the terms of the Finsbury Food Group Long Term Incentive Plan. Of those options 111,000 were granted in terms of the Approved part of the Plan with an exercise price of 27p per share and 1,149,000 options were granted in terms of the Unapproved part of the Plan with an exercise price of 20p per share. The proportion of the options that will vest depends on the growth in adjusted EBITDA over a three-year period. The earliest vesting date is 30th September, 2012.

Following the issue John Duffy will have a beneficial interest in 1,250,781 shares.

For more information, please contact:

Panmure Gordon 020 7459 3600Andrew PottsCallum StewartRedleaf CommunicationsEmma Kane 020 7566 6700Anna Dunkin

vendor
Date   Source Headline
28th May 20199:16 amRNSHolding(s) in Company
29th Apr 20197:00 amRNSDirectorate Change
18th Apr 20194:04 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSDirector/PDMR Shareholding
5th Apr 20197:00 amRNSDirector/PDMR Shareholding
5th Apr 20197:00 amRNSHolding(s) in Company
21st Mar 20195:00 pmRNSEBT Share Purchase
15th Mar 20196:23 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSInterim Results
22nd Jan 20197:00 amRNSExecutive LTIP - PDMR Dealings
16th Jan 20197:00 amRNSPre-Close Trading Update
23rd Nov 20189:08 amRNSAGM Proxy Votes
21st Nov 20181:48 pmRNSResult of AGM
21st Nov 20187:00 amRNSAGM Statement
23rd Oct 20187:00 amRNSAnnual Report and Accounts and Notice of AGM
17th Sep 20187:00 amRNSPreliminary Results
3rd Sep 20187:00 amRNSAcquisition of Ultrapharm Limited
30th Aug 20187:00 amRNSNotice of Results
16th Jul 20187:00 amRNSPre-Close Trading Statement
6th Jul 201810:27 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSHolding(s) in Company
18th Apr 20183:22 pmRNSHolding(s) in Company
10th Apr 201811:00 amRNSHolding(s) in Company
19th Mar 20187:00 amRNSInterim Results
1st Mar 20187:00 amRNSPurchase of Freehold Property
23rd Feb 20187:00 amRNSAmendment and extension of bank facilities
14th Feb 20187:00 amRNSNotice of Results
18th Jan 20187:00 amRNSPre-Close Trading Statement
18th Dec 201711:35 amRNSHolding(s) in Company
22nd Nov 20173:00 pmRNSResult of AGM
22nd Nov 20177:00 amRNSTrading Update
21st Nov 20177:00 amRNSHolding(s) in Company
27th Oct 20177:01 amRNSPDMR Dealings
27th Oct 20177:00 amRNSExecutive LTIP - PDMR Dealings
20th Oct 20177:00 amRNSAnnual Report and Accounts and Notice of AGM
6th Oct 20177:00 amRNSClosure of Grain D'Or and Trading Update
21st Sep 20172:33 pmRNSHolding(s) in Company
18th Sep 20177:00 amRNSPreliminary Results
31st Aug 20177:00 amRNSNotice of Results
23rd Aug 20177:00 amRNSProposed closure of Grain D'Or
17th Jul 20177:00 amRNSPre-Close Trading Statement
3rd Jul 20177:00 amRNSBoard Changes
9th May 20174:11 pmRNSHolding(s) in Company
5th May 20171:47 pmRNSHolding(s) in Company
12th Apr 201712:49 pmRNSDirector/PDMR Shareholding
7th Apr 20172:25 pmRNSDirector/PDMR Shareholding
23rd Mar 20175:25 pmRNSHolding(s) in Company
20th Mar 20177:00 amRNSInterim Results
15th Mar 20171:51 pmRNSHolding(s) in Company
3rd Feb 20177:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.